Symmetry Investments’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,500	Closed	-$401K	–	201
2024 Q1	$401K	Buy	+1,500	New	+$401K	0.02%	125
2023 Q4	–	Sell	-2,000	Closed	-$292K	–	191
2023 Q3	$292K	Buy	+2,000	New	+$292K	0.06%	113
2023 Q2	–	Hold	0	–	–	–	164